Human Lactoferrin Activates NF-kappaB Through the Toll-like Receptor 4 Pathway While It Interferes with the Lipopolysaccharide-stimulated TLR4 Signaling
Overview
Authors
Affiliations
Lactoferrin (LF) has been implicated in innate immunity. Here we reveal the signal transduction pathway responsible for human LF (hLF)-triggered nuclear factor-kappaB (NF-kappaB) activation. Endotoxin-depleted hLF induces NF-kappaB activation at physiologically relevant concentrations in the human monocytic leukemia cell line, THP-1, and in mouse embryonic fibroblasts (MEFs). In MEFs, in which both tumor necrosis factor receptor-associated factor 2 (TRAF2) and TRAF5 are deficient, hLF causes NF-kappaB activation at a level comparable to that seen in wild-type MEFs, whereas TRAF6-deficient MEFs show significantly impaired NF-kappaB activation in response to hLF. TRAF6 is known to be indispensable in leading to NF-kappaB activation in myeloid differentiating factor 88 (MyD88)-dependent signaling pathways, while the role of TRAF6 in the MyD88-independent signaling pathway has not been clarified extensively. When we examined the hLF-dependent NF-kappaB activation in MyD88-deficient MEFs, delayed, but remarkable, NF-kappaB activation occurred as a result of the treatment of cells with hLF, indicating that both MyD88-dependent and MyD88-independent pathways are involved. Indeed, hLF fails to activate NF-kappaB in MEFs lacking Toll-like receptor 4 (TLR4), a unique TLR group member that triggers both MyD88-depependent and MyD88-independent signalings. Importantly, the carbohydrate chains from hLF are shown to be responsible for TLR4 activation. Furthermore, we show that lipopolysaccharide-induced cytokine and chemokine production is attenuated by intact hLF but not by the carbohydrate chains from hLF. Thus, we present a novel model concerning the biological function of hLF: hLF induces moderate activation of TLR4-mediated innate immunity through its carbohydrate chains; however, hLF suppresses endotoxemia by interfering with lipopolysaccharide-dependent TLR4 activation, probably through its polypeptide moiety.
da Silva Junior W, de Oliveira Costa K, Castro Oliveira H, Antunes M, Mafra K, Nakagaki B J Lipid Res. 2025; 66(2):100744.
PMID: 39814317 PMC: 11849619. DOI: 10.1016/j.jlr.2025.100744.
Antioxidant Potential of Lactoferrin and Its Protective Effect on Health: An Overview.
Rascon-Cruz Q, Siqueiros-Cendon T, Sianez-Estrada L, Villasenor-Rivera C, Angel-Lerma L, Olivas-Espino J Int J Mol Sci. 2025; 26(1.
PMID: 39795983 PMC: 11719613. DOI: 10.3390/ijms26010125.
Cidem A, Chang G, Yen C, Chen M, Yang S, Chen C Sci Rep. 2024; 14(1):31210.
PMID: 39732873 PMC: 11682196. DOI: 10.1038/s41598-024-82514-4.
Immunomodulatory effect of bovine lactoferrin during SARS-CoV-2 infection.
da Silva A, Machado T, Nascimento R, Rodrigues M, Coelho F, Tubarao L Front Immunol. 2024; 15:1456634.
PMID: 39483459 PMC: 11524939. DOI: 10.3389/fimmu.2024.1456634.
The Modulation of Septic Shock: A Proteomic Approach.
Alves P, de Souza A, Bastos V, Miguel E, Ramos A, Cameron L Int J Mol Sci. 2024; 25(19).
PMID: 39408970 PMC: 11476436. DOI: 10.3390/ijms251910641.